Motivated To Lead Podcast - Mark Klingsheim

This week we interviewed Brennan Marilla. Brennan has a 30-year track record of driving growth and commercializing transformative therapies in med-tech. He currently serves as Chief Commercial & Operating Officer for Israeli start-up OSSIO, where he has helped build one of the fastest growing, disruptive companies in the orthopedic implant market over the last 6 years. Before OSSIO, he was Chief Commercial Officer for Surgical Specialties Corp (now Corza Medical), where significant improvements in top and bottom-line performance for the contract manufacturer led to a successful acquisition by Vivo Capital in 2017. Prior, he was VP & GM of Covidien’s $650M Endovascular business and VP, Sales and Marketing for their $1B+ Peripheral Vascular sector. In his tenure, these franchises rapidly transformed into a market-leading brand through multiple product introductions, disruptive technology acquisitions, and market development campaigns.    Before Covidien, he spent 12 years at Medtronic where he was VP, U